Experimental infection of reindeer with cervid herpesvirus 2.
Cervid herpesvirus 2 (CvHV2) has been isolated from reindeer (Rangifer tarandus tarandus), and serological data indicate that in reindeer this virus is endemic in Fennoscandia, Alaska, Canada, and Greenland. CvHV2 has been described as a cause of subclinical genital infections in reindeer, but little information on primary infections exists. In this study, six seronegative and presumably pregnant reindeer were allocated to one of two groups. Two animals were inoculated with CvHV2 intratracheally, and two animals intravaginally, with one control animal in each group receiving sterile water. Mild hyperthermia and serous discharges from the vagina and nose were observed. No abortions were recorded, but one calf died shortly after birth. Inoculated animals seroconverted and had neutralizing antibodies after days 7 to 10 postinfection. CvHV2 was detected by PCR in nasal and vaginal swabs from animals in both groups but could be isolated only from nasal swabs in the respiratory group and from vaginal swabs in the genital group. CvHV2 was detected by PCR in various organs and tissues postmortem. In control animals, the virus could not be isolated in spite of PCR-positive nasal and vaginal swab samples and some degree of positive immunostaining. One of the animals that were inoculated intratracheally developed a hemorrhagic, necrotizing bronchopneumonia, which was CvHV2 positive by PCR and immunohistochemistry. We conclude that CvHV2 can cause systemic infection, that both genital and respiratory inoculations can lead to virus shedding, and that the virus can infect the fetus in utero.
Section of Arctic Veterinary Medicine, Department of Food Safety and Infection Biology, The Norwegian School of Veterinary Science, Stakkevollveien 23, NO-9010 Tromsø, Norway. carlos.neves@veths.no
Carlos G
CG
das Neves
Torill
T
Mørk
Jacques
J
Godfroid
Karen K
KK
Sørensen
Eva
E
Breines
Ellinor
E
Hareide
Julien
J
Thiry
Espen
E
Rimstad
Etienne
E
Thiry
Morten
M
Tryland
D000818:Animals; D057134:Antibodies, Neutralizing / Q000097:blood*; D000914:Antibodies, Viral / Q000097:blood*; D005260:Female; D005333:Fetus / Q000276:immunology / Q000821:virology; D006566:Herpesviridae Infections / Q000276:immunology / Q000662:veterinary* / Q000821:virology; D008168:Lung / Q000276:immunology / Q000473:pathology / Q000821:virology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology / Q000662:veterinary* / Q000821:virology; D012053:Reindeer / Q000276:immunology / Q000821:virology*; D014599:Uterus / Q000276:immunology / Q000473:pathology / Q000821:virology; D014621:Vagina / Q000276:immunology / Q000821:virology; D018140:Varicellovirus / Q000276:immunology*; D017201:Virus Shedding / Q000276:immunology
D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral